U.S., July 22 -- ClinicalTrials.gov registry received information related to the study (NCT07716579) titled 'Endocrine and Metabolic Late Effects After Childhood Brain Tumor Treatment' on July 15.
Brief Summary: This prospective single-group clinical study evaluates late endocrine and metabolic consequences in survivors of primary brain tumors treated during childhood in Slovenia.
Participants were treated for a primary brain tumor between 2008 and 2018 while aged 0 to 18 years and survived for at least 5 years after diagnosis. They undergo a standardized multidisciplinary assessment during follow-up. The assessment includes review of medical history and previous cancer treatment, anthropometric measurements, blood pressure measurement, c...